Proteolytic processing of cut homeobox 1 by neutrophil elastase in the MV4;11 myeloid leukemia cell line

Molecular Cancer Research

Volumn 6, Issue 4, 2008, Pages 644-653

  Goulet, Brigitte ^a   Markovic, Yelena ^a,b   Leduy, Lam ^a   Nepveu, Alain ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CUT HOMEOBOX 1 PROTEIN; CYCLIN E; ELASTASE INHIBITOR; HOMEODOMAIN PROTEIN; LEUKOCYTE ELASTASE; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE; GENE REPRESSION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; NEUTROPHIL ELASTASE GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

CELL EXTRACTS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN E; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID; LEUKOCYTE ELASTASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; TETRADECANOYLPHORBOL ACETATE;

MUS MUSCULUS;

EID: 42049109922     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0268     Document Type: Article

References (40)

1. Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000;100:391-8.
2. Hoppe T, Rape M, Jentsch S. Membrane-bound transcription factors: regulated release by RIP or RUP. Curr Opin Cell Biol 2001;13:344-8.
3. Goulet B, Nepveu A. Complete and limited proteolysis in cell cycle progression. Cell Cycle 2004;3:986-9.
4. Lane AA, Ley TJ. Neutrophil elastase cleaves PML-RARα and is important for the development of acute promyelocytic leukemia in mice. Cell 2003;115:305-18.
5. Lane AA, Ley TJ. Neutrophil elastase is important for PML-retinoic acid receptor a activities in early myeloid cells. Mol Cell Biol 2005;25:23-33.
6. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 2001;270:1-15.
7. Scherer SW, Rommens JM, Soder S, et al. Refined localization and yeast artificial chromosome (YAC) contig-mapping of genes and DNA segments in the 7q21-32 region. Hum Mol Genet 1993;2:751-60.
8. Blochlinger K, Bodmer R, Jack J, Jan LY, Jan YN. Primary structure and expression of a product from cut, a locus involved in specifying sensory organ identity in Drosophila. Nature 1988;333:629-35.
9. Neufeld EJ, Skalnik DG, Lievens PM, Orkin SH. Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut. Nat Genet 1992;1:50-5.
10. Valarche I, Tissier-Seta JP, Hirsch MR, Martinez S, Goridis C, Brunet JF. The mouse homeodomain protein Phox2 regulates Ncam promoter activity in concert with Cux/CDP and is a putative determinant of neurotransmitter phenotype. Development 1993;119:881-96.
11. Maitra U, Seo J, Lozano MM, Dudley JP. Differentiation-induced cleavage of Cutl1/CDP generates a novel dominant-negative isoform that regulates mammary gene expression. Mol Cell Biol 2006;26:7466-78.
12. Moon NS, Berube G, Nepveu A. CCAAT displacement activity involves Cut repeats 1 and 2, not the Cut homeodomain. J Biol Chem 2000;275:31325-34.
13. Goulet B, Watson P, Poirier M, et al. Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells. Cancer Res 2002;62:6625-33.
14. Moon NS, Premdas P, Truscott M, Leduy L, Berube G, Nepveu A. S Phase-specific proteolytic cleavage is required to activate stable DNA binding by the CDP/Cut homeodomain protein. Mol Cell Biol 2001;21:6332-45.
15. Truscott M, Raynal L, Premdas P, et al. CDP/Cux stimulates transcription from the DNA polymerase α gene promoter. Mol Cell Biol 2003;23:3013-28.
16. Truscott M, Raynal L, Wang Y, Berube G, Leduy L, Nepveu A. The N-terminal region of the CCAAT displacement protein (CDP)/Cux transcription factor functions as an autoinhibitory domain that modulates DNA binding. J Biol Chem 2004;279:49787-94.
17. Goulet B, Baruch A, Moon NS, et al. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 2004;14:207-19.
18. Sansregret L, Goulet B, Harada R, et al. The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase. Mol Cell Biol 2006;26:2441-55.
19. Holthuis J, Owen TA, van Wijnen AJ, et al. Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science 1990;247:1454-7.
20. van Wijnen AJ, van Gurp MF, de Ridder MC, et al. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F. Proc Natl Acad Sci U S A 1996;93:11516-21.
21. De Vos J, Thykjaer T, Tarte K, et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 2002;21:6848-57.
22. Michl P, Ramjaun AR, Pardo OE, et al. CUTL1 is a target of TGF(β) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 2005;7:521-32.
23. Moon NS, Rong Zeng W, Premdas P, Santaguida M, Berube G, Nepveu A. Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas. Int J Cancer 2002;100:429-32.
24. Goulet B, Sansregret L, Leduy L, et al. Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 2007;5:899-907.
25. Cadieux C, Fournier S, Peterson AC, Bédard C, Bedell BJ, Nepveu A. Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia. Cancer Res 2006;66:9492-501.
26. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O. Single-copy transgenic mice with chosen-site integration [see comments]. Proc Natl Acad Sci U S A 1996;93:9067-72.
27. Lange B, Valtieri M, Santoli D, et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 1987;70:192-9.
28. Hebert S, Bérubé G, Nepveu A. Development of an in vitro assay for the proteolytic processing of the CDP/Cux transcription factor. J Biochem Mol Biol 2003;36:390-8.
29. Yoshimura K, Crystal RG. Transcriptional and posttranscriptional modulation of human neutrophil elastase gene expression. Blood 1992;79:2733-40.
30. Reilly JJ, Jr., Chen P, Sailor LZ, Mason RW, Chapman HA, Jr. Uptake of extracellular enzyme by a novel pathway is a major determinant of cathepsin L levels in human macrophages. J Clin Invest 1990;86:176-83.
31. Schuermann M, Jager R, Salge U, Risse-Hackl G, Havemann K, Heidtmann HH. Control of proteinase expression by phorbol-ester- and Fos-dependent pathways in human non-small-cell lung-cancer cells. Int J Cancer 1997;71:275-83.
32. Akli S, Keyomarsi K. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy. Cancer Biol Ther 2003;2:S38-47.
33. Porter DC, Zhang N, Danes C, et al. Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol 2001;21:6254-69.
34. Ledford AW, Brantley JG, Kemeny G, et al. Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia. Dev Biol 2002;245:157-71.
35. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002;8:979-86.
36. Rios-Doria J, Day KC, Kuefer R, et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 2003;278:1372-9.
37. Marambaud P, Shioi J, Serban G, et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002;21:1948-56.
38. Wang XD, Rosales JL, Magliocco A, Gnanakumar R, Lee KY. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 2003;22:769-74.
39. Keyomarsi K, Tucker SL, Buchholz TA, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347:1566-75.
40. Carragher NO, Westhoff MA, Riley D, et al. v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation. Mol Cell Biol 2002;22:257-69.